An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma
Thomas E. Witzig(WinnMed), Julie M. Vose(University of Nebraska at Omaha), Pier Luigi Zinzani(Istituto Oncologico Romagnolo), Craig B. Reeder(Mayo Clinic in Arizona), Rena Buckstein(Sunnybrook Health Science Centre), Jonathan Polikoff(Kaiser Permanente San Diego Medical Center), Réda Bouabdallah(Institut Paoli-Calmettes), Corinne Haïoun(Hôpitaux Universitaires Henri-Mondor), Hervé Tilly(Centre Henri Becquerel), Pi Guo(Bristol-Myers Squibb (Switzerland)), Dennis Pietronigro(Bristol-Myers Squibb (Switzerland)), A. Ervin-Haynes(Bristol-Myers Squibb (Switzerland)), M. S. Czuczman(Roswell Park Comprehensive Cancer Center)
Cited by 393Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis